Search Results - Nicholas D. Gollop
- Showing 1 - 7 results of 7
-
1
-
2
Prescribing in Type 2 Diabetes Patients With and Without Cardiovascular Disease History: A Descriptive Analysis in the UK CPRD by Ruth Farmer, Ivan Beard, Syed Raza, Nicholas D. Gollop, N. Patel, Abigail Tebboth, Andrew McGovern, Naresh Kanumilli, Andrew Ternouth
Published 2021Artigo -
3
Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of <scp>EMPEROR‐Reduced</scp> by Gerasimos Filippatos, Stefan D. Anker, Javed Butler, Dimitrios Farmakis, João Pedro Ferreira, Nicholas D. Gollop, Martina Brueckmann, Tomoko Iwata, Stuart Pocock, Faı̈ez Zannad, Milton Packer
Published 2022Artigo -
4
Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial by Stuart Pocock, João Pedro Ferreira, John Gregson, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Nicholas D. Gollop, Tomoko Iwata, Martina Brueckmann, James L. Januzzi, Adriaan A. Voors, Faı̈ez Zannad, Milton Packer
Published 2021Artigo -
5
Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age by Michael Böhm, Javed Butler, Gerasimos Filippatos, João Pedro Ferreira, Stuart Pocock, Amr Abdin, Felix Mahfoud, Martina Brueckmann, Nicholas D. Gollop, Tomoko Iwata, Piotr Ponikowski, Christoph Wanner, Faı̈ez Zannad, Milton Packer, Stefan D. Anker
Published 2022Artigo -
6
Long-lasting blood pressure lowering effects of nitrite are NO-independent and mediated by hydrogen peroxide, persulfides, and oxidation of protein kinase G1α redox signalling by Martin Feelisch, Takaaki Akaike, Kayleigh Griffiths, Tomoaki Ida, Oleksandra Prysyazhna, Joanna Jane Goodwin, Nicholas D. Gollop, Bernadette Fernandez, Magdalena Minnion, Miriam M. Cortese‐Krott, Alessandra Borgognone, Rosie M Hayes, Philip Eaton, Michael Frenneaux, Melanie Madhani
Published 2019Artigo -
7
Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin by Nikolaus Marx, Ahmed A. Kolkailah, Julio Rosenstock, Odd Erik Johansen, Mark E. Cooper, John H. Alexander, Robert D. Toto, Christoph Wanner, Mark A. Espeland, Michaela Mattheus, Sven Schnaidt, Vlado Perkovic, Nicholas D. Gollop, Darren K. McGuire
Published 2024Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Cardiology
Diabetes mellitus
Endocrinology
Ejection fraction
Heart failure
Type 2 diabetes
Biochemistry
Blood pressure
Chemistry
Empagliflozin
Intensive care medicine
Adverse effect
Alternative medicine
Biology
Biomarker
Cardiomyopathy
Cell biology
Descriptive statistics
Disease
Etiology
Family medicine
Gold standard (test)
Hemodynamics
Hydrogen peroxide
Hypoglycemia
Inorganic chemistry
Kinase
Law